Brought to you by 
Tularik completes $96mm IPO
13 Oct 2011
Executive Summary
Tularik (small molecule drug discovery based on gene regulation) completed an initial public offering of 6.95mm shares at $14 each, netting $96mm. The company initially hoped to raise about $40mm, originally filing 6.25mm shares at an expected price of $11-13. Concurrent with the offering, the company's largest shareholder, Pharma Vision 2000, will buy shares at the offering price to maintain its 23.5% stake.
Deal Industry
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Tularik completes $96mm IPO
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice